Evocutis seeks to accelerate growth

First published in Business news

SKINCARE products business Evocutis is considering a sale or merger to accelerate its growth.

The business, which tests skincare products at its laboratory in Wetherby, said it was evaluating a number of options which would enable it to benefit from a collaboration with a major strategic partner.

The business was launched last year after Syntopix, a Bradford-based company that develops antimicrobial skin products for the cosmetics industry, bought Leeds Skin Centre For Applied Research, which has developed LabSkin, a living skin that can be used for testing products.

The business has increased revenues from £227,000 in 2011 to £457,000 in the year ended July 31.

Dr Gwyn Humphreys, interim chief executive officer, said: “These results show that the integration of Syntopix and Leeds Skin into Evocutis has led to significant growth in collaborations with major multi-national companies.

“Evocutis aims to increase these relationships over the next twelve months, and to increase the availability of LabSkin for those companies who wish to carry out research in-house.”

Comments

Comments are closed on this article.

Send us your news, pictures and videos

Most read stories

Local Info

Enter your postcode, town or place name

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree